Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 215

    1.

    Education and imaging. Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging.

    Eso Y, Marusawa H, Osaki Y.

    J Gastroenterol Hepatol. 2012 Feb;27(2):416. doi: 10.1111/j.1440-1746.2011.06988.x. No abstract available.

    PMID:
    22260287
    [PubMed - indexed for MEDLINE]
    2.

    Education and imaging. Hepatobiliary and Pancreatic: Aberrant hepatic arteries and pancreatic surgery.

    Mizuno S, Kato H, Kishiwada M, Sakurai H, Suzaki M, Noguchi T, Isaji S.

    J Gastroenterol Hepatol. 2012 Feb;27(2):415. doi: 10.1111/j.1440-1746.2011.06989.x. No abstract available.

    PMID:
    22260286
    [PubMed - indexed for MEDLINE]
    3.

    Education and imaging. Hepatobiliary and pancreatic: bleeding vaginal varices.

    Garg M, Lee S, Brooks M, Gow P.

    J Gastroenterol Hepatol. 2012 Jan;27(1):185. doi: 10.1111/j.1440-1746.2011.06982.x. No abstract available.

    PMID:
    22188032
    [PubMed - indexed for MEDLINE]
    4.

    Education and imaging. Hepatobiliary and pancreatic: hepatosplenic gamma-delta T-cell lymphoma.

    Qi X, Han G, He C, Guo W, Fan D.

    J Gastroenterol Hepatol. 2012 Jan;27(1):184. doi: 10.1111/j.1440-1746.2011.06983.x. No abstract available.

    PMID:
    22188031
    [PubMed - indexed for MEDLINE]
    5.

    How does hepatitis B virus infection react to hepatocellular carcinoma treatment?

    Wong GL.

    J Gastroenterol Hepatol. 2012 Jan;27(1):1-2. doi: 10.1111/j.1440-1746.2011.06950.x. No abstract available.

    PMID:
    22188022
    [PubMed - indexed for MEDLINE]
    6.

    CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation.

    Tonan T, Fujimoto K, Qayyum A, Morita Y, Nakashima O, Ono N, Kawahara A, Kage M, Hayabuchi N, Ueno T.

    J Gastroenterol Hepatol. 2012 Apr;27(4):789-96. doi: 10.1111/j.1440-1746.2011.07057.x.

    PMID:
    22188204
    [PubMed - in process]
    7.

    Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.

    Zhang X, Li N, Li X, Zhao W, Qiao Y, Liang L, Ding Y.

    J Gastroenterol Hepatol. 2012 Jun;27(6):1117-25. doi: 10.1111/j.1440-1746.2011.07049.x.

    PMID:
    22168621
    [PubMed - in process]
    8.

    Bone marrow cells: important role on neovascularization of hepatocelluar carcinoma.

    Zhu H, Shao Q, Sun X, Deng Z, Yuan X, Zhou X, Ding Y.

    J Gastroenterol Hepatol. 2011 Dec 6. doi: 10.1111/j.1440-1746.2011.07044.x. [Epub ahead of print]

    PMID:
    22142567
    [PubMed - as supplied by publisher]
    9.

    Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis.

    Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O, Fiorentino F, Vecchione R, D' Angelo S.

    J Gastroenterol Hepatol. 2012 Apr;27(4):813-22. doi: 10.1111/j.1440-1746.2011.07043.x.

    PMID:
    22142548
    [PubMed - in process]
    10.

    Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?

    Chow PK.

    J Gastroenterol Hepatol. 2012 Mar;27(3):452-7. doi: 10.1111/j.1440-1746.2011.07034.x.

    PMID:
    22142283
    [PubMed - in process]
    11.

    Education and imaging. Hepatobiliary and pancreatic: Niemann-Pick disease.

    Hasosah M, Satti M.

    J Gastroenterol Hepatol. 2011 Dec;26(12):1813. doi: 10.1111/j.1440-1746.2011.06935.x. No abstract available.

    PMID:
    22097942
    [PubMed - indexed for MEDLINE]
    12.

    Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?

    Chien RN.

    J Gastroenterol Hepatol. 2011 Dec;26(12):1699-701. doi: 10.1111/j.1440-1746.2011.06931.x. No abstract available.

    PMID:
    22097937
    [PubMed - indexed for MEDLINE]
    13.

    Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export.

    Chen Y, Chen Y, Zhao L, Chen Y, Mei M, Li Q, Huang A, Varghese Z, Moorhead JF, Ruan XZ.

    J Gastroenterol Hepatol. 2012 May;27(5):974-84. doi: 10.1111/j.1440-1746.2011.06986.x.

    PMID:
    22098164
    [PubMed - in process]
    14.

    Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma.

    Kim HY, Park JW, Joo J, Jung SJ, An S, Woo SM, Kim HB, Koh YH, Lee WJ, Kim CM.

    J Gastroenterol Hepatol. 2012 Jun;27(6):1051-6. doi: 10.1111/j.1440-1746.2011.06963.x.

    PMID:
    22098152
    [PubMed - in process]
    15.

    Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma.

    Ogunwobi OO, Wang T, Zhang L, Liu C.

    J Gastroenterol Hepatol. 2012 Mar;27(3):566-78. doi: 10.1111/j.1440-1746.2011.06980.x.

    PMID:
    22097969
    [PubMed - in process]
    16.

    Education and imaging. Hepatobiliary and pancreatic: Clip migration after laparoscopic cholecystectomy.

    Tseng CW, Wei CK, Hsieh YH.

    J Gastroenterol Hepatol. 2011 Nov;26(11):1695. doi: 10.1111/j.1440-1746.2011.06906.x. No abstract available.

    PMID:
    22011303
    [PubMed - indexed for MEDLINE]
    17.

    Education and imaging. Hepatobiliary and pancreatic: Blocked metal biliary stent.

    Awad S, Zaitoun AM, Lobo DN.

    J Gastroenterol Hepatol. 2011 Nov;26(11):1694. doi: 10.1111/j.1440-1746.2011.06905.x. No abstract available.

    PMID:
    22011302
    [PubMed - indexed for MEDLINE]
    18.

    Dihydrolipoyl histidinate zinc complex, a new antioxidant, attenuates hepatic ischemia-reperfusion injury in rats.

    Masuda T, Iwashita Y, Hagiwara S, Ohta M, Inomata M, Noguchi T, Kitano S.

    J Gastroenterol Hepatol. 2011 Nov;26(11):1652-8. doi: 10.1111/j.1440-1746.2011.06773.x.

    PMID:
    22011298
    [PubMed - indexed for MEDLINE]
    19.

    Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.

    Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.

    J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.

    PMID:
    22011297
    [PubMed - indexed for MEDLINE]
    20.

    Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma.

    Miyahara K, Nouso K, Tomoda T, Kobayashi S, Hagihara H, Kuwaki K, Toshimori J, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Yamamoto K.

    J Gastroenterol Hepatol. 2011 Nov;26(11):1604-11. doi: 10.1111/j.1440-1746.2011.06887.x.

    PMID:
    22011296
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk